During the past decade, Hospital de Braga; Servico de Neurologia conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 4 clinical trials were completed, i.e. on average, 44.4% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 3 clinical trials were completed. i.e. 75% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Hospital de Braga; Servico de Neurologia" are "Alzheimer Disease" (2 trials), "Diabetic Macular Edema" (2 trials), "Alzheimer's Disease" (1 trials), "Multiple Sclerosis" (1 trials) and "Multiple Sclerosis, Primary Progressive" (1 trials). Many other conditions were trialed in "Hospital de Braga; Servico de Neurologia" in a lesser frequency.

Most popular intervention types in "Hospital de Braga; Servico de Neurologia" are "Drug" (10 trials), "Procedure" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Ocrelizumab" (4 trials), "Faricimab" (3 trials), "Sham Procedure" (3 trials), "Aflibercept" (2 trials) and "Gantenerumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Hospital de Braga; Servico de Neurologia" are 10 trials for "All" genders.

Currently, there are NaN active trials in "Hospital de Braga; Servico de Neurologia". undefined are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Hospital de Braga; Servico de Neurologia, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital de Braga; Servico de Neurologia, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".